323 related articles for article (PubMed ID: 22777357)
1. Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming.
Zhang X; Cruz FD; Terry M; Remotti F; Matushansky I
Oncogene; 2013 May; 32(18):2249-60, 2260.e1-21. PubMed ID: 22777357
[TBL] [Abstract][Full Text] [Related]
2. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated Reprogramming.
Tiemann U; Wu G; Marthaler AG; Schöler HR; Tapia N
Stem Cell Reports; 2016 Jan; 6(1):35-43. PubMed ID: 26711876
[TBL] [Abstract][Full Text] [Related]
4. Efficient induction of pluripotent stem cells from granulosa cells by Oct4 and Sox2.
Mao J; Zhang Q; Ye X; Liu K; Liu L
Stem Cells Dev; 2014 Apr; 23(7):779-89. PubMed ID: 24083387
[TBL] [Abstract][Full Text] [Related]
5. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
6. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency.
Yamakawa T; Sato Y; Matsumura Y; Kobayashi Y; Kawamura Y; Goshima N; Yamanaka S; Okita K
Stem Cells; 2016 Nov; 34(11):2661-2669. PubMed ID: 27335261
[TBL] [Abstract][Full Text] [Related]
7. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
8. Gata4 blocks somatic cell reprogramming by directly repressing Nanog.
Serrano F; Calatayud CF; Blazquez M; Torres J; Castell JV; Bort R
Stem Cells; 2013 Jan; 31(1):71-82. PubMed ID: 23132827
[TBL] [Abstract][Full Text] [Related]
9. A combined epigenetic and non-genetic approach for reprogramming human somatic cells.
Han J; Sachdev PS; Sidhu KS
PLoS One; 2010 Aug; 5(8):e12297. PubMed ID: 20808872
[TBL] [Abstract][Full Text] [Related]
10. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
[TBL] [Abstract][Full Text] [Related]
11. Reprogramming cancer cells: back to the future.
Lang JY; Shi Y; Chin YE
Oncogene; 2013 May; 32(18):2247-8. PubMed ID: 22869153
[TBL] [Abstract][Full Text] [Related]
12. Porcine induced pluripotent stem cells produce chimeric offspring.
West FD; Terlouw SL; Kwon DJ; Mumaw JL; Dhara SK; Hasneen K; Dobrinsky JR; Stice SL
Stem Cells Dev; 2010 Aug; 19(8):1211-20. PubMed ID: 20380514
[TBL] [Abstract][Full Text] [Related]
13. Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes.
Farthing CR; Ficz G; Ng RK; Chan CF; Andrews S; Dean W; Hemberger M; Reik W
PLoS Genet; 2008 Jun; 4(6):e1000116. PubMed ID: 18584034
[TBL] [Abstract][Full Text] [Related]
14. Defined factors induce reprogramming of gastrointestinal cancer cells.
Miyoshi N; Ishii H; Nagai K; Hoshino H; Mimori K; Tanaka F; Nagano H; Sekimoto M; Doki Y; Mori M
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):40-5. PubMed ID: 20018687
[TBL] [Abstract][Full Text] [Related]
15. NANOG priming before full reprogramming may generate germ cell tumours.
Grad I; Hibaoui Y; Jaconi M; Chicha L; Bergström-Tengzelius R; Sailani MR; Pelte MF; Dahoun S; Mitsiadis TA; Töhönen V; Bouillaguet S; Antonarakis SE; Kere J; Zucchelli M; Hovatta O; Feki A
Eur Cell Mater; 2011 Nov; 22():258-74; discussio 274. PubMed ID: 22071697
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
17. Generation of Partially Reprogrammed Cells and Fully Reprogrammed iPS Cells by Plasmid Transfection.
Kim JS; Choi HW; Hong YJ; Do JT
Methods Mol Biol; 2016; 1357():85-95. PubMed ID: 25476445
[TBL] [Abstract][Full Text] [Related]
18. Rapid and efficient reprogramming of human amnion-derived cells into pluripotency by three factors OCT4/SOX2/NANOG.
Zhao HX; Li Y; Jin HF; Xie L; Liu C; Jiang F; Luo YN; Yin GW; Li Y; Wang J; Li LS; Yao YQ; Wang XH
Differentiation; 2010; 80(2-3):123-9. PubMed ID: 20510497
[TBL] [Abstract][Full Text] [Related]
19. Induced pluripotent stem cell lines derived from human somatic cells.
Yu J; Vodyanik MA; Smuga-Otto K; Antosiewicz-Bourget J; Frane JL; Tian S; Nie J; Jonsdottir GA; Ruotti V; Stewart R; Slukvin II; Thomson JA
Science; 2007 Dec; 318(5858):1917-20. PubMed ID: 18029452
[TBL] [Abstract][Full Text] [Related]
20. ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells.
Jung L; Tropel P; Moal Y; Teletin M; Jeandidier E; Gayon R; Himmelspach C; Bello F; André C; Tosch A; Mansouri A; Bruant-Rodier C; Bouillé P; Viville S
Mol Hum Reprod; 2014 Jun; 20(6):538-49. PubMed ID: 24501429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
